Joanne Donovan
Direttore Tecnico/Scientifico/R&S presso EDGEWISE THERAPEUTICS, INC.
Patrimonio netto: 340 836 $ in data 31/05/2024
Profilo
Joanne M.
Donovan is currently the Chief Medical Officer at Edgewise Therapeutics, Inc. She previously worked as the Medical Director at GelTex Pharmaceuticals, Inc. and as the Vice President-Clinical Development at Genzyme Corp.
from 1998 to 2011.
From 2011 to 2021, she served as the Chief Medical Officer & SVP-Clinical Development at Astria Therapeutics, Inc. Additionally, she holds the position of Associate Clinical Professor at Harvard Medical School.
Dr. Donovan obtained her doctorate degrees from Massachusetts Institute of Technology and Harvard Medical School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/05/2024 | 19 897 ( 0.02% ) | 340 836 $ | 31/05/2024 |
Posizioni attive di Joanne Donovan
| Società | Posizione | Inizio |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 27/04/2021 |
Precedenti posizioni note di Joanne Donovan
| Società | Posizione | Fine |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 23/04/2021 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
| Harvard Medical School | Corporate Officer/Principal | - |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Joanne Donovan
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| EDGEWISE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Joanne Donovan
